| 支架联合125I粒子条植入术治疗上腔静脉综合征 |
| |
| 引用本文： | 宋梦瑶,张程智,孙占国,刘一铭,许凯豪,韩新巍,焦德超.支架联合125I粒子条植入术治疗上腔静脉综合征[J].中国介入影像与治疗学,2023,20(10):577-581. |
| |
| 作者姓名： | 宋梦瑶 张程智 孙占国 刘一铭 许凯豪 韩新巍 焦德超 |
| |
| 作者单位： | 郑州大学第一附属医院放射介入科, 河南 郑州 450052 |
| |
| 基金项目： | 河南省科技攻关项目(232102311132)、河南省重大科技专项项目(221100310100)。 |
| |
| 摘 要： | 目的 观察支架联合125I粒子条植入术治疗上腔静脉综合征(SVCS)的短期效果。方法 回顾性分析40例SVCS,其中23例接受上腔静脉支架植入术(支架组)、17例接受支架联合125I粒子条植入术(联合组);比较组间技术成功率、临床成功率、并发症发生率、支架通畅率,以及患者肿瘤无进展生存期(PFS)和总生存期(OS)的差异。结果 2组技术成功率均为100%;联合组与支架组临床成功率(94.12% vs. 91.30%)、并发症发生率(17.65% vs. 8.70%),术后1个月支架通畅率(100% vs. 91.30%)、2个月支架通畅率(100% vs. 82.61%),以及患者中位PFS(4.12个月vs. 3.83个月)和中位OS(22.44个月vs. 20.36个月)差异均无统计学意义(P均>0.05)。术后4个月联合组支架通畅率高于支架组(100% vs. 78.26%,P<0.05)。结论 支架联合125I粒子条植入术治疗SVCS短期效果确切。
|
| 关 键 词： | 上腔静脉综合征 支架 碘同位素 |
| 收稿时间： | 2023/4/7 0:00:00 |
| 修稿时间： | 2023/5/2 0:00:00 |
Stent and 125I seeds strand implantation for treating superior vena cava syndrome |
| |
| SONG Mengyao,ZHANG Chengzhi,SUN Zhanguo,LIU Yiming,XU Kaihao,HAN Xinwei,JIAO Dechao.Stent and 125I seeds strand implantation for treating superior vena cava syndrome[J].Chinese Journal of Interventional Imaging and Therapy,2023,20(10):577-581. |
| |
| Authors: | SONG Mengyao ZHANG Chengzhi SUN Zhanguo LIU Yiming XU Kaihao HAN Xinwei JIAO Dechao |
| |
| Affiliation: | Department of Interventional Radiology, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China |
| |
| Abstract: | Objective To explore the short-term efficacy of stent and 125I seeds strand implantation for treating superior vena cava syndrome (SVCS). Methods Data of 40 patients with SVCS, including 23 patients who underwent superior vena cava (SVC) stent implantation alone (stent group) and 17 underwent stent and 125I seeds strand implantation (combined group) were retrospectively analyzed. The technical success rate, clinical success rate, complication rate, stent patency rate, and tumor progression free survival (PFS) and overall survival (OS) were compared between groups. Results The technical success rate was 100% in both groups. No significant difference of clinical success rate (94.12% vs. 91.30%), complication rate (17.65% vs. 8.70%), stent patency rate 1 (100% vs. 91.30%) and 2 months after implantation (100% vs. 82.61%), nor of median PFS (4.12 months vs. 3.83 months) and median OS (22.44 months vs. 20.36 months) was found between groups (all P>0.05). Four months after implantation, the stent patency rate in combined group was higher than in stent group (100% vs. 78.26%, P<0.05). Conclusion Stent and 125I seeds strand implantation had definite short-term efficacy for treating SVCS. |
| |
| Keywords: | superior vena cava syndrome stents iodine isotopes |
|
| 点击此处可从《中国介入影像与治疗学》浏览原始摘要信息 |
|
点击此处可从《中国介入影像与治疗学》下载全文 |
|
